Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies
April 29, 2024 07:30 ET
|
Cognition Therapeutics, Inc.
PURCHASE, N.Y., April 29, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative...
KANZHUN LIMITED Files Its Annual Report on Form 20-F
April 29, 2024 07:30 ET
|
Kanzhun Limited
BEIJING, April 29, 2024 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced it filed its...
UMB Announces Agreement to Acquire Heartland Financial
April 29, 2024 07:30 ET
|
Heartland Financial USA, Inc.
Largest acquisition in UMB history will increase total assets by more than 40% and significantly expand geographic footprint UMB investment community call today, Monday, April 29, at 7:30 a.m. (CT) /...
Heartland Financial USA, Inc. ("HTLF") Reports Quarterly Results as of March 31, 2024
April 29, 2024 07:30 ET
|
Heartland Financial USA, Inc.
First Quarter Highlights •Quarterly net income available to common stockholders of $49.7 million or $1.16 per common share•Adjusted earnings available to common stockholders of $52.4 million or $1.22...
Zevra Therapeutics’ President and Chief Executive Officer Issues Letter to Stockholders Highlighting Recent Key Accomplishments and Outlook for 2024
April 29, 2024 07:30 ET
|
Zevra Therapeutics
CELEBRATION, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that Neil F. McFarlane,...
Streamline Health® Expands eValuator™ Footprint With Existing Client
April 29, 2024 07:30 ET
|
Streamline Health Solutions, Inc.
Following an efficient implementation process, a leading Florida-based healthcare provider is expanding its footprint and utilization of eValuator Atlanta, GA, April 29, 2024 (GLOBE NEWSWIRE) --...
Dragonfly Energy to Report First Quarter 2024 Financial and Operational Results on May 14, 2024
April 29, 2024 07:30 ET
|
Dragonfly Energy Holdings Corp.
Dragonfly Energy to release Q1 2024 financial and operational results on May 14, 2024, after market close, followed by an earnings call at 5pm ET.
Intellia Therapeutics to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024
April 29, 2024 07:30 ET
|
Intellia Therapeutics, Inc.
Extended follow-up will include safety, kallikrein reduction and attack rate data, including number of patients who continue to be completely attack free through the latest follow-upIntellia to host...
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
April 29, 2024 07:30 ET
|
Bioventus, Inc.
DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
April 29, 2024 07:25 ET
|
ALTERITY THERAPEUTICS LIMITED
– New Evidence Indicates ATH434 can Function as an Iron Chaperone to Redistribute Iron – MELBOURNE, Australia and SAN FRANCISCO, April 29, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX:...